GlyNAC is a combination of two amino acids, glycine and N-acetylcysteine (NAC), and it has become a popular alternative to taking glutathione itself.
The idea is simple. Your body builds glutathione from three amino acids: glutamate, cysteine, and glycine. NAC supplies cysteine, glycine supplies glycine, so taking both is meant to give your body the raw materials.
The research is more mixed than the headlines suggest. Two human trials looked at GlyNAC in older adults and reached different conclusions about glutathione. This guide explains what each one found, why they differ, and what the limits are.
What Is GlyNAC?
GlyNAC simply means glycine plus NAC, taken together. It is not a single patented compound, and it is different from the glutathione capsules and liposomal products we cover in our best liposomal glutathione supplements guide.
Our guide on NAC vs. glutathione explains why NAC is used as a precursor. GlyNAC adds the second ingredient that some researchers believe becomes limiting as we age.
The Theory Behind It
The research team behind the 16-week trial below has proposed that older adults may be short of the building blocks, which could limit how much glutathione the body can make. The reasoning is that supplying both glycine and cysteine should help restore production.
That is a hypothesis, and the studies below are how it has been tested so far.
Trial 1: The 16-Week Baylor Trial
A randomized, placebo-controlled trial in the Journals of Gerontology, Series A enrolled 24 older adults and 12 young adults. The older adults received either GlyNAC or an alanine placebo for 16 weeks, and the young adults received GlyNAC for 2 weeks (Kumar et al., 2023).
The doses were 100 mg per kilogram of body weight per day of each amino acid. For a 70 kg adult, that works out to roughly 7 g of glycine and 7 g of NAC daily, by our own arithmetic. That is a lot more than typical supplement labels suggest.
The authors reported that GlyNAC improved glutathione levels, oxidative stress, markers of mitochondrial function, inflammation, and measures of physical function compared with placebo, and that the supplement was well tolerated. The study reported no conflicts of interest and was funded by the U.S. National Institute on Aging and a philanthropic gift.
The authors themselves state limits:
- The participants were healthier than typical older adults, so results may not apply to people with other health conditions.
- Larger trials are needed.
- Quality-of-life scores did not improve.
- Some of the aging-related outcomes were added as exploratory measures after the trial had started.
Trial 2: The 14-Day Dose-Ranging Trial
A second randomized, double-blind, placebo-controlled trial, published in Frontiers in Aging, enrolled 117 healthy adults aged 60 to 85 across four arms: placebo and three GlyNAC doses of 2.4, 4.8, and 7.2 g per day, split between morning and evening. It lasted 14 days (Lizzo et al., 2022).
The main result was a surprise. Total blood glutathione at the end of the study did not differ significantly from placebo at any dose. The ratio of reduced to oxidized glutathione did not change significantly either.
In a post hoc subgroup, about 27.5% of participants who started with high oxidative damage and low glutathione did show a rise at the medium and high doses. A post hoc finding is a lead for future research, not a confirmed result.
The authors reported no severe adverse events and no discontinuations due to adverse effects. One participant withdrew because of high blood pressure.
There are limits here too:
- The trial was only 14 days.
- Only whole blood was measured, so effects inside tissues remain unknown.
- Several authors work for Nestlé Health Science, which holds patents and licenses for glycine and NAC use and markets related products. The trial was conducted by a research institute that Nestlé funded.
Why the Two Trials Disagree
We can’t say for certain, but several differences are worth noting.
Duration. Sixteen weeks versus two weeks. Glutathione-related changes may take longer to appear.
Participants and size. The first trial was small (12 older adults per arm) and the second larger (about 29 per arm).
What was measured. The two trials did not use identical outcome measures, and the second looked at whole blood.
Dose. The first used a weight-based dose that works out higher than the second’s top dose for most adults.
None of this means one trial is right and the other wrong. It means GlyNAC’s effect on glutathione isn’t settled, and larger, longer, independent trials would help.
What About Other Studies?
A 2026 narrative review in Frontiers in Nutrition summarizes further human work, including a 36-week open-label study, a meal-challenge trial, and a 14-day pilot in people with type 2 diabetes. It describes GlyNAC as a promising “proof-of-concept” approach, not an established treatment (Wang et al., 2026).
The review also notes that most human studies are small, some are short, several findings come from post hoc subgroup analyses, and many outcomes come from the same few trials. It is a narrative review, not a systematic one, so it is not a substitute for a formal meta-analysis.
GlyNAC vs. Taking Glutathione Directly
This is where the comparison gets practical.
Oral glutathione has its own mixed record, which we cover in our guide to S-acetyl vs. liposomal vs. reduced glutathione. GlyNAC takes a different route by supplying building blocks rather than the finished molecule.
No study we found compares GlyNAC head to head with any glutathione form. So we can’t say which raises glutathione better, and anyone claiming one is clearly superior is going beyond the evidence.
Safety and Side Effects
In both trials above, the authors described GlyNAC as well tolerated over the study periods. Those periods were short (2 to 16 weeks), so long-term safety remains unstudied.
NAC on its own commonly causes digestive side effects. WebMD lists diarrhea, nausea or vomiting, upset stomach, and rash, and warns about severe allergic reactions. It says to stop and get help right away if you have trouble breathing, facial or throat swelling, or dizziness or fainting. The Frontiers review says stomach effects become more common at oral doses above 70 mg/kg.
WebMD also names two medicine classes to discuss with a provider before using NAC: nitrates, used for chest pain, and pirfenidone (Esbriet), used for idiopathic pulmonary fibrosis. It notes that NAC’s interactions with medicines are not fully understood. See our guides on glutathione side effects and drug interactions.
On pregnancy and breastfeeding, WebMD says it is not known how NAC could affect pregnancy or whether it passes into breast milk. We cover the topic for glutathione in our pregnancy and breastfeeding guide.
Who Should Talk to a Healthcare Provider First
Ask your doctor or pharmacist before trying GlyNAC if you:
- Are pregnant, planning pregnancy, or breastfeeding
- Take nitrates, pirfenidone, or any other prescription medication
- Have a heart, liver, kidney, or lung condition
- Are undergoing chemotherapy or radiation
- Are allergic to NAC or any ingredient in the product
- Are scheduled for surgery
What About Dose?
We can’t give a recommended dose. The trials above used doses set by researchers under medical supervision, and they were not designed to establish what is right for the general public.
If you decide to use a GlyNAC product, follow the label, avoid exceeding it, and discuss it with your healthcare provider first. For context on glutathione itself, see how much glutathione to take daily.
Food First
Glycine and cysteine also come from protein-rich foods, and sulfur-rich vegetables support your body’s own glutathione production. Our guide on foods that boost glutathione naturally is a sensible starting point before adding a supplement.
FAQs
GlyNAC is a combination of glycine and N-acetylcysteine (NAC). The two amino acids are building blocks the body uses to make glutathione.
Results differ. A 16-week trial in 24 older adults reported improved glutathione levels, while a 14-day trial in 117 older adults found no significant difference from placebo overall, with a rise only in a post hoc subgroup.
Not shown. No study we found compared them directly, so no one can say which is better.
We can’t recommend a dose. The trials used researcher-set doses, one based on body weight and one at 2.4 to 7.2 g per day. Follow the product label and ask your healthcare provider.
That is not established. Some trials reported improvements in markers linked to aging, but these were small studies, several outcomes were exploratory or post hoc, and long-term results are unknown.
In the trials, it was described as well tolerated over 2 to 16 weeks, but long-term safety hasn’t been studied. NAC alone can cause nausea, diarrhea, and rash, and a severe allergic reaction is possible. People who are pregnant, breastfeeding, taking medication, or managing a health condition should check with a healthcare provider first.
Final Thoughts
GlyNAC is a reasonable idea backed by early, small, and conflicting research. One 16-week trial reported encouraging results, and a larger 14-day trial found no overall glutathione change, with a benefit only in a subgroup identified after the fact.
If you’re curious, treat it as experimental, check with a healthcare provider, and don’t expect it to replace a good diet. If you prefer a direct approach, our best liposomal glutathione supplements guide compares options by dose and testing.
This article is general information and not a substitute for medical advice. GlyNAC and glutathione supplements are not a treatment or cure for any condition.
References
- Kumar P, Liu C, Suliburk J, Hsu JW, Muthupillai R, Jahoor F, Minard CG, Taffet GE, Sekhar RV. Supplementing glycine and N-acetylcysteine (GlyNAC) in older adults improves glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, physical function, and aging hallmarks: a randomized clinical trial. J Gerontol A Biol Sci Med Sci. 2023;78(1):75–89. Houston Methodist Scholars
- Lizzo G, Migliavacca E, Lamers D, et al. A randomized controlled clinical trial in healthy older adults to determine efficacy of glycine and N-acetylcysteine supplementation on glutathione redox status and oxidative damage. Front Aging. 2022;3:852569. Frontiers / BORIS
- Wang X, Hou R, Chen Z, Wang X, Wang H. Glycine and N-acetylcysteine supplementation, with or without exercise, in brain health and functional aging: implications for sarcopenia and frailty in older adults. Front Nutr. 2026;13. Frontiers
- WebMD. N-Acetyl Cysteine (NAC): Overview, Uses, Side Effects, Precautions, Interactions, Dosing and Reviews. WebMD